Cornerstone Therapeutics Appoints Vincent Morgus as CFO

Cornerstone Therapeutics, a specialty pharmaceutical company, has appointed Vincent Morgus as executive vice president (EVP), finance and chief financial officer (CFO). Morgus joins the company’s executive management team and will manage its finance function. He will report to Craig Collard, Cornerstone’s president and chief executive officer (CEO).

Morgus joins Cornerstone from Quintiles, where he has been senior vice president (SVP), corporate development since September 2003. He joined Quintiles in June 1994 and progressed through a variety of financial management positions within the Quintiles organisation, including vice president, finance of Quintiles Americas and CFO of Quintiles Informatics.

Prior to working at Quintiles, Morgus held controller positions at Q+E Software and DaVinci Systems. He started his career as an auditor for Arthur Andersen in northern California. Morgus earned his MBA from the University of North Carolina’s Kenan-Flagler Business School and his BSc from the Pennsylvania State University’s Smeal College of Business.


Related reading